The US-EU trade agreement may increase the costs of the pharmaceutical sector by $ 19 billion

Analysts argue that the transaction between the EU and the US may increase the costs of the pharmaceutical sector by $ 19 billion. Reuters writes about it, noting that the additional costs of pharmaceutical companies as a result of the agreement are likely. It will be $ 13 to $ 19 billion. Brand medicines 15%...